The financing resulted in total gross proceeds of $200,000. The company intends to use the net proceeds from this private placement to satisfy certain amounts owed to Cato Research, a contract research organization and a related party to Cato BioVentures.
Alseres has granted incidental registration rights to Cato BioVentures covering resale of the shares of common stock issued in the private placement.